| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0015 | 1 |